Form 4 Tracker
SOLENO THERAPEUTICS INC
SLNO

15 insider filings · Latest: May 18, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 27, 2026Mar 31 8:17 PMMeredith ManningChief Commercial Officer
Sale
7,522$30.44$229.0K64,507(D)

View →

Mar 27, 2026Mar 31 8:15 PMMichael F. HuangSr. VP of Clinical Development
Sale
6,582$30.44$200.4K39,823(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 18, 2026May 18 4:52 PMKristen YenOfficer title: SVP Global Clinical Operations and Patient Advocacy
Disposition
141,410$51.150(D)

View →

May 18, 2026May 18 4:49 PMBirgitte VolckDirector
Disposition
22,090$51.150(D)

View →

May 18, 2026May 18 4:47 PMAndrew SinclairDirector
Disposition
22,913$51.150(D)

View →

May 18, 2026May 18 4:44 PMMatthew PaulsDirector
Disposition
9,063$4.600(D)

View →

May 18, 2026May 18 4:42 PMKevin NorrettChief Business Officer
Disposition
68,286$47.250(D)

View →

May 18, 2026May 18 4:41 PMMeredith ManningChief Commercial Officer
Disposition
153,000$49.170(D)

View →

May 18, 2026May 18 4:39 PMManher JoshiChief Development Officer
Disposition
77,021$46.310(D)

View →

May 18, 2026May 18 4:38 PMMichael F. HuangSr. VP of Clinical Development
Disposition
135,700$49.170(D)

View →

May 18, 2026May 18 4:36 PMPatricia C HiranoOfficer title: Senior Vice President, Regulatory Affairs
Disposition
127,582$51.150(D)

View →

May 18, 2026May 18 4:32 PMJennifer FulkCHIEF FINANCIAL OFFICER
Disposition
67,660$39.060(D)

View →

May 18, 2026May 18 4:27 PMBhatnagar AnishDirector, CHIEF EXECUTIVE OFFICER
Disposition
763,112$51.150(D)

View →